It’s as shady as it sounds.
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Patients and doctors got a chance to share their nightmarish experiences with medical bills with President Donald Trump and other top White House officials.
Top House Republican also received more than $1 million from drugmakers since 2007.
En su libro de memorias, la ex primera dama relata la dolorosa experiencia que tuvieron que vivir con Barack Obama al perder un embarazo.
The attention may help women understand that miscarriage is common but still not easily talked about.
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
Though Rep. Tom MacArthur (R-N.J.) counts himself a moderate, many of his voters heading to the polls are furious about how he aided his party’s efforts to dismantle Obamacare.
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
As Republican and Democratic attorneys general square off on a Texas case that threatens to dismantle consumer protections in the federal health law, campaigns across the country for states’ highest legal officer get hotter.
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
The six-term Arizona senator, who died Saturday, took on some of health care’s goliaths, such as the tobacco industry and insurance companies, in addition to the health law.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
After being promised a significant discount for paying cash upfront and forgoing insurance, a Wisconsin patient gets caught in the middle between hospital and insurer — and feels snookered by a last-minute surprise and billing snafu.
Cash-strapped school boards, cities and legislatures scrounge to cover pay raises and pricey benefits and turn to teachers to fork over more of their shrinking take-home pay.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.